Patents by Inventor Thomas P. Poirier

Thomas P. Poirier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
    Patent number: 5162226
    Abstract: Non-virulent aro-Salmonella typhimurium bacterium is disclosed into which has been cloned a heterologous nucleotide sequence encoding for the expression of Streptococcal M protein antigen from S. pyogenes seratype 5, which is effective to elicit opsonic antibodies against Streptococcal infections. The bacterium is useful for vaccination against Streptococcus pyogenes bacteria.
    Type: Grant
    Filed: August 24, 1987
    Date of Patent: November 10, 1992
    Assignee: University of Tennessee Research Corp. (U.T.R.C.)
    Inventors: Edwin H. Beachey, Thomas P. Poirier, Michael A. Kehoe
  • Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
    Patent number: 5124153
    Abstract: Non-virulent bacteria are disclosed into which have been cloned heterologous nucleotide sequences encoded for the expression of Streptococcal M protein antigens, which are effective to elicit opsonic antibodies against Streptococcal infections. These bacteria are useful for vaccination against Streptococcus pyogenes bacteria.
    Type: Grant
    Filed: August 9, 1989
    Date of Patent: June 23, 1992
    Assignee: University of Tennessee Research Corp.
    Inventors: Edwin H. Beachey, Thomas P. Poirier, Michael A. Kehoe